Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 26-29 September 2022 3 October 2022 All news https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-26-29-september-2022
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022 30 September 2022 All news https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-12-15-september-2022
Update on the surveillance of vaccines and treatments against the Monkeypox virus 23 September 2022 All news https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-et-traitements-contre-le-virus-monkeypox
Meeting highlights from the CHMP – 12-15 September 2022 16 September 2022 All news EU-Meeting-highlights-from-the-CHMP-12-15-September-2022-1Télécharger
Final programming Document 13 September 2022 All news https://www.ema.europa.eu/en/documents/report/final-programming-document-2022-2024_en.pdf
Guidance on releasing information from adverse reaction and medical device incident reports to the public 9 September 2022 All news Canada-Guidance-on-releasing-information-from-AR-and-MDI-reports_Aug2022-1Télécharger
Sweden: Developments regarding the monitoring of adverse events 5 September 2022 All news Sweden-Developments-regarding-the-monitoring-of-adverse-events_-16Aug2022-1Télécharger
Guidance for applicants/MAHs 2 September 2022 All news EU-Guidance-for-applicants_MAHs-involved-in-GMP-and-GCP-inspections-co-ordinated-by-EMA_-V3.0-2Télécharger
